Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06515457 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Evaluate the Efficacy of an Oral Supplement in Supporting Vision and Eye Health
A NA study of Eye Health and Inflammation Symptoms, sponsored by Bio Nature Health.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06515457: Completed NA study of Eye Health and Inflammation Symptoms, sponsored by Bio Nature Health.
NCT06515457 is a NA study of Eye Health and Inflammation Symptoms that has completed, run by Bio Nature Health. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06515457, a NA study of Eye Health and Inflammation Symptoms, has completed, sponsored by Bio Nature Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the efficacy of BioNatureHealth's Eye Empower supplement in supporting vision and eye health. It is a virtual, single-group trial lasting 3 weeks. Participants will take three capsules of the supplement daily and complete questionnaires at Baseline, Week 1, Week 2, and Week 3 to assess visual clarity, dryness, symptoms of inflammation, and sensitivity to blue light.
Primary Outcome
Participants will report on their visual clarity through self-reported questionnaires. The questionnaires will evaluate changes in visual clarity from baseline.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Eye Empower
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
What the finished NCT06515457 record still lists
NCT06515457 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Eye Health appearing as the primary indexed condition, and to 1 intervention - of which Eye Empower is the first listed.
NCT06515457 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06515457 about?
NCT06515457 is a clinical study titled "A Clinical Trial to Evaluate the Efficacy of an Oral Supplement in Supporting Vision and Eye Health". This study aims to evaluate the efficacy of BioNatureHealth's Eye Empower supplement in supporting vision and eye health. It is a virtual, single-group trial lasting 3 weeks. Participants will take three capsules of the supplement daily and complete questionnaires at Baseline, Week 1, Week 2, and We...
What is the current status of trial NCT06515457?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-04-22. Estimated completion is 2024-06-01.
What conditions does trial NCT06515457 study?
This clinical trial studies the following conditions: Eye Health, Inflammation Symptoms, Eye Dryness.
What interventions are being tested in trial NCT06515457?
The interventions under investigation include: Eye Empower (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06515457?
This trial is sponsored by Bio Nature Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06515457 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06515457's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI